Pisa syndrome in Parkinson's disease: diagnostic and management challenges

References

• Ekbom K, Lindholm H, Ljungberg L. New dystonic syndrome associated with butyrophenone therapy. Z Neurol. 1972;202(2):94–103.
   PubMedGoogle Scholar
• Vanacore N, Suzzareddu G, Maggini M, Casula A, Capelli P, Raschetti R. Pisa syndrome in a cohort of Alzheimer’s disease patients. Acta Neurol Scand. 2005;111(3):199–201.
   Web of Science ®Google Scholar
• Shinfuku M, Nakajima S, Uchida H, Watanabe K, Kocha H, Kashima H. Pisa syndrome caused by an acetylcholinesterase inhibitor in a patient with dementia with Lewy bodies. Psychiatry Clin Neurosci. 2011;65(3):299.
   Web of Science ®Google Scholar
• Cannas A, Solla P, Floris G, Borghero G, Tacconi P, Spissu A. Reversible Pisa syndrome in Parkinson’s disease during treatment with Pergolide: a case report. Clin Neuropharm. 2005;28(5):252–253.
   Web of Science ®Google Scholar
• Gambarin M, Antonini A, Moretto G, et al. Pisa syndrome without neuroleptic exposure in a patient with Parkinson’s disease: case report. Mov Disord. 2006;21(2):270–273.
   Web of Science ®Google Scholar
• Harada K. Pisa syndrome without neuroleptic exposure in a patient with Parkinson’s disease: a case report. Mov Disord. 2006;21(12):2264–2265.
   Web of Science ®Google Scholar
• Kim JS, Park JW, Chung SW, Kim YI, Kim HT, Lee KS. Pisa syndrome as a motor complication of Parkinson’s disease. Parkinsonism Relat Disord. 2007;13(2):126–128.
   Web of Science ®Google Scholar
• Colosimo C. Pisa syndrome in a patient with multiple system atrophy. Mov Disord. 1998;13(3):607–609.
   Web of Science ®Google Scholar
• Solla P, Cannas A, Costantino E, Orofino G, Lavra L, Marrosu F. Pisa syndrome in a patient with progressive supranuclear palsy. J Clin Neurosci. 2012;19(6):922–923.
   Web of Science ®Google Scholar
• Salazar Z, Tschopp L, Calandra C, Micheli F. Pisa syndrome and parkinsonism secondary to valproic acid in Huntington’s disease. Mov Disord. 2008;23(16):2430–2431.
   Web of Science ®Google Scholar
• Leon-Sarmiento FE, Pradilla G, Del Rosario Zambrano M. Primary and reversible Pisa syndrome in juvenile normal pressure hydrocephalus. Acta Neuropsychiatr. 2013;25(1):57–60.
   Web of Science ®Google Scholar
• Marchione P, Spallone A, Valente M, Giannone C, De Angelis F, Meco G. Reversible Pisa syndrome associated to subdural haematoma: case report. BMC Neurol. 2014;14:149.
   Web of Science ®Google Scholar
• Malhotra HS, Garg RK. Pearls and Oy-sters: Pisa syndrome: an unusual feature of adult-onset fulminant SSPE. Neurology. 2015;84(3):e12–e14.
   Web of Science ®Google Scholar
• Bhattacharya KF, Giannakikou I, Munroe N, et al. Primary anticholinergic-responsive Pisa syndrome. Mov Disord. 2000;15(6):1285–1287.
   Web of Science ®Google Scholar
• Cannas A, Solla P, Floris G, et al. Reversible Pisa syndrome in patients with Parkinson’s disease on dopaminergic therapy. J Neurol. 2009;256(3):390–395.
   Web of Science ®Google Scholar
• Solla P, Cannas A, Congia S, et al. Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson’s disease patient. J Neurol Sci. 2008;275(1–2):154–156.
   Web of Science ®Google Scholar
• Galati S, Möller JC, Städler C. Ropinirole-induced Pisa syndrome in Parkinson disease. Clin Neuropharmacol. 2014;37(2):58–59.
   PubMed Web of Science ®Google Scholar
• Fasano A, Di Matteo A, Vitale C, et al. Reversible Pisa syndrome in patients with Parkinson’s disease on rasagiline therapy. Mov Disord. 2011;26(14):2578–2580.
   Web of Science ®Google Scholar
• Suzuki T, Matsuzaka H. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management. CNS Drugs. 2002;16(3):165–174.
   PubMed Web of Science ®Google Scholar
• Stübner S, Padberg F, Grohmann R, et al. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry. 2000;61(8):569–574.
   PubMedGoogle Scholar
• Villarejo A, Camacho A, García-Ramos R, et al. Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol. 2003;26(3):119–121.
   PubMed Web of Science ®Google Scholar
• Zannas AS, Okuno Y, Doraiswamy PM. Cholinesterase inhibitors and Pisa syndrome: a pharmacovigilance study. Pharmacotherapy. 2014;34(3):272–278.
   Web of Science ®Google Scholar
• Yohanan M, Aulakh JS, Weith J, et al. Pisa syndrome in a patient in a wheelchair taking valproic acid. Am J Psychiatry. 2006;163(2):325–326.
   Web of Science ®Google Scholar
• Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003;18(5):467–486.
   PubMed Web of Science ®Google Scholar
• Ashour R, Jankovic J. Joint and skeletal deformities in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Mov Disord. 2006;21(11):1856–1863.
   PubMed Web of Science ®Google Scholar
• Parkinson J. An Essay on the Shaking Palsy. London: Whittingham and Rowland; 1817.
   Google Scholar
• Doherty KM, van de Warrenburg BP, Peralta MC, et al. Postural deformities in Parkinson’s disease. Lancet Neurol. 2011;10(6):538–549.
   PubMed Web of Science ®Google Scholar
• Tinazzi M, Fasano A, Geroin C, et al. Pisa syndrome in Parkinson disease: an observational multicenter Italian study. Neurology. 2015;85(20):1769–1779.
   PubMed Web of Science ®Google Scholar
• Bonanni L, Thomas A, Varanese S, Scorrano V, Onofrj M. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism. Mov Disord. 2007;22(14):2097–2103.
   Web of Science ®Google Scholar
• Baik JS, Kim JY, Park JH, Han SW, Park JH, Lee MS. Scoliosis in patients with Parkinson’s disease. J Clin Neurol. 2009;5(2):91–94.
   PubMed Web of Science ®Google Scholar
• Grimes JD, Hassan MN, Trent G, Halle D, Armstrong GW. Clinical and radiographic features of scoliosis in Parkinson’s disease. Adv Neurol. 1987;45:353–355.
   Google Scholar
• Castrioto A, Piscicelli C, Pérennou D, Krack P, Debû B. The pathogenesis of Pisa syndrome in Parkinson’s disease. Mov Disord. 2014;29(9):1100–1107.
   PubMed Web of Science ®Google Scholar
• Ungerstedt U, Butcher LL, Butcher SG, Anden NE, Fuxe K. Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 1969;14(2):461–471.
   Web of Science ®Google Scholar
• Herrera-Marschitz M, Utsumi H, Ungerstedt U. Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation. J Neurol Neurosurg Psychiatry. 1990;53(1):39–43.
   Web of Science ®Google Scholar
• Duvoisin RC, Marsden CD. Note on the scoliosis of Parkinsonism. J Neurol Neurosurg Psychiatry. 1975;38(8):787–793.
   Web of Science ®Google Scholar
• Indo T, Ando K. Studies on the scoliosis of Parkinsonism. Rinsho Shinkeigaku. 1980;20(1):40–46.
   Google Scholar
• Di Matteo A, Fasano A, Squintani G, et al. Lateral trunk flexion in Parkinson’s disease: EMG features disclose two different underlying pathophysiological mechanisms. J Neurol. 2011;258(5):740–745.
   Web of Science ®Google Scholar
• Vorovenci RJ, Biundo R, Antonini A. Therapy-resistant symptoms in Parkinson’s disease. J Neural Transm. 2016;123(1):19–30.
   Web of Science ®Google Scholar
• Shih LC, Vanderhorst VG, Lozano AM, Hamani C, Moro E. Improvement of pisa syndrome with contralateral pedunculopontine stimulation. Mov Disord. 2013;28(4):555–556.
   PubMed Web of Science ®Google Scholar
• van de Warrenburg BP, Bhatia KP, Quinn NP. Pisa syndrome after unilateral pallidotomy in Parkinson’s disease: an unrecognised, delayed adverse event? J Neurol Neurosurg Psychiatry. 2007;78(3):329–330.
   Web of Science ®Google Scholar
• Spanaki C, Zafeiris S, Plaitakis A. Levodopa-aggravated lateral flexion of the neck and trunk as a delayed phenomenon of unilateral pallidotomy. Mov Disord. 2010;25(5):655–656.
   Web of Science ®Google Scholar
• Benatru I, Vaugoyeau M, Azulay JP. Postural disorders in Parkinson’s disease. Neurophysiol Clin. 2008;38(6):459–465.
   Web of Science ®Google Scholar
• Vaugoyeau M, Azulay JP. Role of sensory information in the control of postural orientation in Parkinson’s disease. J Neurol Sci. 2010;289(1–2):66–68.
   Web of Science ®Google Scholar
• Pereira CB, Kanashiro AK, Maia FM, Barbosa ER. Correlation of impaired subjective visual vertical and postural instability in Parkinson’s disease. J Neurol Sci. 2014;346(1–2):60–65.
   Web of Science ®Google Scholar
• Scocco DH, Wagner JN, Racosta J, Chade A, Gershanik OS. Subjective visual vertical in Pisa syndrome. Parkinsonism Relat Disord. 2014;20(8):878–883.
   Web of Science ®Google Scholar
• Pastor MA, Day BL, Marsden CD. Vestibular induced postural responses in Parkinson’s disease. Brain. 1993;116(Pt 5):1177–1190.
   PubMedGoogle Scholar
• Vitale C, Marcelli V, Furia T, et al. Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion. Mov Disord. 2011;26(8):1458–1463.
   PubMed Web of Science ®Google Scholar
• Horak FB. Postural orientation and equilibrium: what do we need to know about neural control of balance to prevent falls? Age Ageing. 2006;35(Suppl 2):ii7–ii11.
   PubMed Web of Science ®Google Scholar
• Vitale C, Falco F, Trojano L, et al. Neuropsychological correlates of Pisa syndrome in patients with Parkinson’s disease. Acta Neurol Scand. Epub 2015 Oct 2. doi: 10.1111/ane.12514.
   Google Scholar
• Tinazzi M, Juergenson I, Squintani G, et al. Pisa syndrome in Parkinson’s disease: an electrophysiological and imaging study. J Neurol. 2013;260(8):2138–2148.
   Web of Science ®Google Scholar
• Tassorelli C, Furnari A, Buscone S, et al. Pisa syndrome in Parkinson’s disease: clinical, electromyographic, and radiological characterization. Mov Disord. 2012;27(2):227–235.
   PubMed Web of Science ®Google Scholar
• Frazzitta G, Balbi P, Gotti F, et al. Pisa syndrome in Parkinson’s disease: electromyographic aspects and implication for rehabilitation. Parkinsons Dis. 2015;2015:437190. doi: 10.1155/2015/437190.
   Web of Science ®Google Scholar
• Doherty KM, Davagnanam I, Molloy S, Silveira-Moriyama L, Lees AJ. Pisa syndrome in Parkinson’s disease: a mobile or fixed deformity? J Neurol Neurosurg Psychiatry. 2013;84(12):1400–1403.
   PubMed Web of Science ®Google Scholar
• Miletić V, Radić B, Relja M. Acute pisa syndrome as a neurological emergency. J Neuropsychiatry Clin Neurosci. 2015;27(2):e159–e160.
   Web of Science ®Google Scholar
• Yokochi F. Lateral flexion in Parkinson’s disease and Pisa syndrome. J Neurol 2006;253(Suppl 7):VII17–VII20.
   Web of Science ®Google Scholar
• Abboud H, Sivaraman I, Ontaneda D, Tavee J. Camptocormia and Pisa syndrome as manifestations of acute myasthenia gravis exacerbation. J Neurol Sci. 2015;359(1–2):8–10.
   Web of Science ®Google Scholar
• Wunderlich S, Csoti I, Reiners K, et al. Camptocormia in Parkinson’s disease mimicked by focal myositis of the paraspinal muscles. Mov Disord. 2002;17(3):598–600.
   Web of Science ®Google Scholar
• Doherty KM, Silveira-Moriyama L, Giladi N, Bhatia KP, Parton M, Lees AJ. Camptocormia: don’t forget muscle disease in the movement disorder clinic. J Neurol. 2012;259(8):1752–1754.
   Web of Science ®Google Scholar
• Michel SF, Oscar AC, Correa TE, Alejandro PL, Micheli F. Pisa syndrome. Clin Neuropharmacol. 2015;38(4):135–140.
   Web of Science ®Google Scholar
• Arora M, Praharaj SK, Sarkar S. Clozapine effective in olanzapine- induced Pisa syndrome. Ann Pharmacother. 2006;40(12):2273–2275.
   Web of Science ®Google Scholar
• Kurtz G, Kapfhammer HP, Peuker B. Pisa syndrome in clozapine therapy. Nervenarzt. 1993;64(11):742–746.
   Web of Science ®Google Scholar
• Walder A, Greil W, Baumann P. Drug-induced Pisa syndromeunder quetiapine. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(7):1286–1287.
   Web of Science ®Google Scholar
• Tassorelli C, De Icco R, Alfonsi E, et al. Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study. Parkinsonism Relat Disord. 2014;20(11):1140–1144.
   Web of Science ®Google Scholar
• Dupeyron A, Viollet E, Coroian F, Gagnard C, Renard D, Castelnovo G. Botulinum Toxin-A for treatment of Pisa syndrome: a new target muscle. Parkinsonism Relat Disord. 2015;21(6):669–670.
   Web of Science ®Google Scholar
• Bartolo M, Serrao M, Tassorelli C, et al. Four-week trunk-specific rehabilitation treatment improves lateral trunk flexion in Parkinson’s disease. Mov Disord. 2010;25(3):325–331.
   PubMed Web of Science ®Google Scholar
• Ricciardi L, Piano C, Bentivoglio AR, Fasano A. Long-term effects of pedunculopontine nucleus stimulation for Pisa syndrome. Parkinsonism Relat Disord. 2014;20(12):1445–1446.
   Web of Science ®Google Scholar